Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
Erica M. Richards, Paolo Zanotti‐Fregonara, Masahiro Fujita, et al.
EJNMMI Research (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 166

Showing 26-50 of 166 citing articles:

Prognosis and Improved Outcomes in Major Depression: A Review
Christoph Kraus, Bashkim Kadriu, Rupert Lanzenberger, et al.
FOCUS The Journal of Lifelong Learning in Psychiatry (2020) Vol. 18, Iss. 2, pp. 220-235
Open Access | Times Cited: 59
Promising Neuroimaging Biomarkers in Depression
Chien‐Han Lai
Psychiatry Investigation (2019) Vol. 16, Iss. 9, pp. 662-670
Open Access | Times Cited: 57
[11C]PBR28 MR–PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder
Nicole R. Zürcher, Marco L. Loggia, Jennifer Mullett, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 5, pp. 1659-1669
Open Access | Times Cited: 54
Neuroinflammation in Major Depressive Disorder: A Review of PET Imaging Studies Examining the 18-kDa Translocator Protein
Davide Gritti, Giuseppe Delvecchio, Adele Ferro, et al.
Journal of Affective Disorders (2021) Vol. 292, pp. 642-651
Closed Access | Times Cited: 45
Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19
Eliza Dąbrowska, Beata Galińska-Skok, Napoleon Waszkiewicz
Life (2021) Vol. 11, Iss. 10, pp. 1056-1056
Open Access | Times Cited: 43
Neuroinflammation in HIV-associated depression: evidence and future perspectives
Arish Mudra Rakshasa-Loots, Heather C. Whalley, Jaime H. Vera, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3619-3632
Open Access | Times Cited: 36
The pandemic brain: Neuroinflammation in non-infected individuals during the COVID-19 pandemic
Ludovica Brusaferri, Zeynab Alshelh, Daniel Martins, et al.
Brain Behavior and Immunity (2022) Vol. 102, pp. 89-97
Open Access | Times Cited: 35
Quercetin abrogates lipopolysaccharide-induced depressive-like symptoms by inhibiting neuroinflammation via microglial NLRP3/NFκB/iNOS signaling pathway
Olusegun Adebayo Adeoluwa, Juliet N. Olayinka, Gladys Onyinye Adeoluwa, et al.
Behavioural Brain Research (2023) Vol. 450, pp. 114503-114503
Closed Access | Times Cited: 21
Major Depressive Disorder and Gut Microbiota: Role of Physical Exercise
Pedro Borges de Souza, Laura A. Borba, Louise Castro de Jesus, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16870-16870
Open Access | Times Cited: 21
Why Are Some People with Lower Urinary Tract Symptoms (LUTS) Depressed? New Evidence That Peripheral Inflammation in the Bladder Causes Central Inflammation and Mood Disorders
Francis M. Hughes, Michael R. Odom, Anissa Cervantes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2821-2821
Open Access | Times Cited: 17
Targeting autophagy to counteract neuroinflammation: A novel antidepressant strategy
Hua Gan, Qingyu Ma, Wenzhi Hao, et al.
Pharmacological Research (2024) Vol. 202, pp. 107112-107112
Open Access | Times Cited: 7
Icariin and icaritin ameliorated hippocampus neuroinflammation via inhibiting HMGB1-related pro-inflammatory signals in lipopolysaccharide-induced inflammation model in C57BL/6 J mice
Lumei Liu, Zhengxiao Zhao, Linwei Lu, et al.
International Immunopharmacology (2019) Vol. 68, pp. 95-105
Closed Access | Times Cited: 51
Roles of multiple lipid mediators in stress and depression
Tomoyuki Furuyashiki, Satoshi Akiyama, Shiho Kitaoka
International Immunology (2019) Vol. 31, Iss. 9, pp. 579-587
Open Access | Times Cited: 50
Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder
Sophia Attwells, Elaine Setiawan, Pablo Rusjan, et al.
Biological Psychiatry (2020) Vol. 88, Iss. 8, pp. 649-656
Closed Access | Times Cited: 49
Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
Kristin Köhler‐Forsberg, Anders Jorgensen, Vibeke H. Dam, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 49
Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know
Theodore A. Henderson, Muriel J. van Lierop, Mary Kay McLean, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 48
PET imaging shows no changes in TSPO brain density after IFN-α immune challenge in healthy human volunteers
Maria Antonietta Nettis, Mattia Veronese, Naghmeh Nikkheslat, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 47
Fronto-limbic neuroimaging biomarkers for diagnosis and prediction of treatment responses in major depressive disorder
Chien‐Han Lai
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 107, pp. 110234-110234
Closed Access | Times Cited: 43
PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study
Stal Shrestha, Min-Jeong Kim, Mark A. G. Eldridge, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 42
Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies
Fabien Chauveau, Guillaume Becker, Hervé Boutin
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 1, pp. 201-220
Open Access | Times Cited: 38
Neuroinflammation as a Common Denominator of Complex Diseases (Cancer, Diabetes Type 2, and Neuropsychiatric Disorders)
Serena Asslih, Odeya Damri, Galila Agam
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6138-6138
Open Access | Times Cited: 36
P2X7R antagonists in chronic stress-based depression models: a review
Iven-Alex von Muecke-Heim, Clemens Ries, Lidia Urbina-Treviño, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 271, Iss. 7, pp. 1343-1358
Open Access | Times Cited: 33
Neuroinflammation, Stress-Related Suicidal Ideation, and Negative Mood in Depression
Sarah Herzog, Elizabeth Bartlett, Francesca Zanderigo, et al.
JAMA Psychiatry (2024)
Closed Access | Times Cited: 6
Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
Zarah R. Haniff, Mariia Bocharova, Tim Mantingh, et al.
Pharmacology & Therapeutics (2024) Vol. 258, pp. 108641-108641
Open Access | Times Cited: 5
Neuroinflammatory activation in sensory and motor regions of the cortex is related to sensorimotor function in individuals with low back pain maintained by nociplastic mechanisms: A preliminary proof‐of‐concept study
Muath A. Shraim, Hugo Massé‐Alarie, Michael J. Farrell, et al.
European Journal of Pain (2024) Vol. 28, Iss. 9, pp. 1607-1626
Open Access | Times Cited: 5

Scroll to top